Myriad Genetics board member Skovronsky resigns

Daniel M. Skovronsky, M.D., Ph.D., a member of the board of directors of Myriad Genetics (NASDAQ: MYGN), resigned from his position effective June 17, 2026.

According to a company statement, Skovronsky's departure was not the result of any disagreement with the company or any matter relating to its operations, policies, or practices.

You May Also Be Interested In

• First Carolina Financial Services CFO to retire in January 2027
• Ximen Mining launches $350,000 bridge placement for Kenville mine
• Kite Realty Group Trust files for 12M share offering by selling stockholders